APVO
Aptevo Therapeutics Inc
NASDAQ: APVO · HEALTHCARE · BIOTECHNOLOGY
$4.81
-1.94% today
Updated 2026-04-29
Market cap
$5.68M
P/E ratio
—
P/S ratio
2.70x
EPS (TTM)
$-87.27
Dividend yield
—
52W range
$4 – $189
Volume
0.1M
Aptevo Therapeutics Inc (APVO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+42.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+96.7%
Most recent quarter
When is the next earnings report?
Reporting date
December 31, 2025
Consensus EPS estimate
$-8.09
Fiscal period ending
2025-12-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+2.8%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-01 | $-5.91 | — | $4.27 | $4.17 | -2.3% |
| 2025-11-06 | $-2.23 | +41.0% | $1.43 | $1.47 | +2.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-5.91 | — | — | — |
| 2025-12-31 | $-8.09 | — | — | $-220000.00 | — |
| 2025-09-30 | $-3.78 | $-2.23 | +41.0% | — | — |
| 2025-06-30 | $-83.20 | $-8.40 | +89.9% | — | — |
| 2025-03-31 | $-84.20 | $-87.80 | -4.3% | — | — |
| 2024-12-31 | $-155.00 | $-178.80 | -15.4% | — | — |
| 2024-09-30 | $-421.80 | $-355.20 | +15.8% | — | — |
| 2024-06-30 | $-6.55 | $-1.67 | +74.5% | — | — |
| 2024-03-31 | $-12.84 | $-9.95 | +22.5% | — | — |
| 2023-12-31 | $-18.04 | $-6.16 | +65.9% | $902000.00 | — |
| 2023-09-30 | $-0.75 | $-0.50 | +33.3% | — | — |
Frequently asked questions
When does Aptevo Therapeutics Inc report next earnings?
Aptevo Therapeutics Inc (APVO) is scheduled to report earnings on December 31, 2025. The consensus EPS estimate is $-8.09.
Has Aptevo Therapeutics Inc beaten earnings estimates?
Aptevo Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +42.2% over the last 3 quarters.
How does APVO stock react to earnings?
APVO stock has moved an average of +0.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.